Documenti e pubblicazioni
Le reti professionali. Rete cardiologica - Area Governo clinico
- Ortolani P et al. Relevance of sex in patients with acute myocardial infarction undergoing coronary interventions. J Cardiovasc Med 2012 Aug 20 [Epub ahead of print]
- Marzocchi A et al. Incidence, treatment and outcome of acute coronary syndromes: a community-based study in the era of myocardial infarction networks. Int J Cardiol 2012;157(3):419-22.
- Bartoli S et al.The cost of innovation in treating aortic stenosis: transcatheter aortic valve implantation. G Ital Cardiol (Rome) 2012;13(1):50-8.
- Berti E et al. Impact of Computed Tomography Coronary Angiography on patterns of care. Effect on Myocardial Perfusion Scintigraphy and Coronary Angiography volumes. Int J Tech Assess Health Care 2012; 28(4):424-8.
- Barbieri A et al. Left ventricular hypertrophy reclassification and death: application of the Recommendation of the American Society of Echocardiography/European Association of Echocardiography. Eur Heart J Cardiovasc Imaging 2012;13(1):109-17.
- Barbieri A et al. Prognostic impact of left ventricular mass severity according to the classification proposed by the American Society of Echocardiography/European Association of Echocardiography. J Am Soc Echocardiogr. 2011 Dec; 24(12):1383-91.
- Pavesi PC et al. L’evoluzione delle unità di terapia intensiva cardiologica nell’era della rete interospedaliera hub e spoke. analisi dell’attività in Emilia-Romagna dal 2002 al 2007. G Ital Cardiol (Rome) 2011; 12 (1): 31-42.
- Valgimigli M et al. Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna) multicenter registry. REAL Registry Investigators. JACC Cardiovasc Interv. 2012 Jan;5(1):23-35.
- Valgimigli M, Saia F, Guastaroba P. Reply to the Editor. JACC. Cardiovasc Interv 2012;5(6):692-3.
- Rubboli A et al. Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry). Am J Cardiology 2012;109(10):1411-7.
- Ortolani P et al. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of Clopidogrel and proton pump inhibitors: results from a regional cohort study. Journal of Cardiovascular Medicine (Hagerstown), 2011 Jan 19.
- Saia F et al. Lower long-term mortality within a Regional system of care for st-elevation myocardial infarction. Acute Cardiac Care 2010; 12, 2, 42-50.
- Ortolani P et al. Long-term effectiveness of early administration of glycoprotein IIB/IIIA agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an st-elevation myocardial infarction network. European Heart Journal 2009; 30, 1, 33-43.
- Saia F et al. Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry. EuroIntervention 2009; 5, 1, 57-66.
- Taglieri N et al. - FATA Trial Investigators - Left ventricular function after st-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and Abciximab or Tirofiban (from the facilitated angioplasty with Tirofiban or Abciximab [FATA] trial). The American Journal of Cardiology 2009;103, 6, 785-790.
- Commissione cardiologica e cardiochirurgica regionale. Stent a rilascio di farmaco per gli interventi di angioplastica coronarica. Valutazione complessiva dell’esperienza della regione Emilia-Romagna a cinque anni dalla loro introduzione. 2008.
- Fiorini M et al. Valutazione dei costi delle procedure di angioplastica coronarica e bypass nel pazienti con patologia coronarica multivasale nelle strutture pubbliche e private. Abstract book Forum italiano per la valutazione delle tecnologie sanitarie, 2007.
- Ortolani P et al. Clinical comparison of “Normal-hours” vs “Off-hours” percutaneos coronary interventions for st-elevation myo cardial infarction. American Heart Journal, 2007; l, 154, 2, 365-372.
- Ortolani P et al. Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.The American journal of cardiology 2007;100(5):787-92.
- Guastaroba P et al. Impact of a regional project on patterns of care for acute myocardial infarction. Italian heart journal: official journal of the Italian Federation of Cardiology 2005;6 Suppl 6:41S-48S.
- Manari A et al. Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry.
Journal of Cardiovascular Medicine 2011; 12, 2, 102-109. - Casella G et al. Off-Hour Primary Percutaneous Coronary Angioplasty Does Not Affect Outcome of Patients With ST-Segment Elevation Acute Myocardial Infarction Treated Within a Regional Network for Reperfusion. JACC Cardiovascular Interventions 2011; 4, 3, 270-278.
- Ortolani P et al. Pre-hospital ECG in patients undergoing primary percutanous interventions within an integrated system of care: reperfusion and long-term survival benefits. EuroIntervention 2011; 7, 4, 449-457.
- Campo G et al. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention. Arch Intern Med 2011, 171, 21, 1.948-1.949.
- Balducelli M et al. Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro regionale angiopLastiche Emilia-Romagna Registry. Catheterization and cardiovascular interventions 2011; 75, 3, 327-334.
- Ortolani P et al. Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions Results from the REAL (REgistro regionale AngiopLastiche Emilia-Romagna) multicenter registry. International Journal of Cardiology 2011.
- Varani E et al. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
EuroIntervention 2010; 5, 8, 953-961. - Agenzia sanitaria e sociale regionale. REAL - Registro REgionale AngiopLastiche Coronariche Innovare la pratica clinica con ricerca, condivisione e responsabilità.
Pensiero Scientifico Editore. 2008. - Vignali L et al. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry). The American Journal of Cardiology 2008, 101, 7, 947-952
- Manari A et al. Clinical impact of an inter-hospital transfer strategy in patients with ST elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute. European Heart Journal 2008; 29, 15, 1834-1842.
- Ortolani P et al. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Circulation 2008, 117, 7, 923-930. - Campo G et al. Long-term outcome after drug eluting stenting in patients with ST-segment Elevation Myocardial Infarction Data from the REAL Registry. International Journal of Cardiology 2010.
- Saia F et al. Optimization of therapeutic strategies for ST-elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality.
Heart 2009, Jul 24. - Ortolani P et al. Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention.
European Heart Journal 2008; 29, 10, 1241-1249. - Grilli R, Guastaroba P, Taroni F. Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneos coronary interventions.
CMAJ 2007; 176, 2, 195-196. - Varani E et al. Percutaneos treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry. EuroIntervention 2007; 2, 4, 474-480.
- Marzocchi A et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Circulation 2007; 115, 25, 3181-3188 - Grilli R., Taroni F. Managing the introduction of expensive medical procedures: use of a registry. Journal of Health Services Research & Policy 2006; 11, 2, 89-93.
- Saia F et al. Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry.
Journal of American College of Cardiology 2006; 48, 7, 1312-1318. - Percoco G. Safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction:the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry. Cardiovascular drugs and therapy 2006; 20, 1, 63-68.
- Marzocchi A et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. The American Journal of Cardiology 2005; 95, 12, 1409-1414.
- Fiorini M, Guastaroba P, Taroni F, Grilli R. Impatto di diverse politiche di adozione nella pratica clinica degli stent a rilascio di farmaco. Politiche sanitarie 2005; 6, 4, 210-218
- Dossier 91/2004. Stent a rilascio di farmaco per gli interventi di angioplastica conorarica. Impatto clinico ed economico.
- Agenzia sanitaria regionale. Valutazione empirica dell´impatto dei DES sulla frequenza di utilizzo delle procedure di rivascolarizzazione coronarica. L'informazione in pillole 4/2004
- Grilli R., Taroni F. Gli studi osservazionali per uscire dall'enigma costo-efficacia. Il Sole 24 Ore Sanità 2002; 5, 27, 18-19.
- Grilli R. Cure di cuore vincenti con la strategia "hub and spoke". Il Sole 24 Ore Sanità, 2002; 5, 34, 2-3